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Abstract
© 2017 Galieva, Mukhamedshina, Arkhipova and Rizvanov. At present there is no effective
treatment of pathologies associated with the death of neurons and glial cells which take place
as a result of physical trauma or ischemic lesions of the nervous system. Thus, researchers have
high hopes for a treatment based on the use of stem cells (SC), which are potentially able to
replace dead cells  and synthesize neurotrophic factors and other molecules that  stimulate
neuroregeneration. We are often faced with ethical issues when selecting a source of SC. In
addition  to  precluding  these,  human  umbilical  cord  blood  (hUCB)  presents  a  number  of
advantages when compared with other sources of SC. In this review, we consider the key
characteristics  of  hUCB,  the  results  of  various  studies  focused  on  the  treatment  of
neurodegenerative  diseases  (Alzheimer's  disease,  Parkinson's  disease,  amyotrophic  lateral
sclerosis), ischemic (stroke) and traumatic injuries of the nervous system and the molecular
mechanisms of hUCB-derived mononuclear and stem cells.
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